ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 359239 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 359239; 2) Community: the network communities that were significantly associated with the response to NSC 359239; 3) Molecule: the relationships between components within communities and NSC 359239; 4) MDR: the compounds that were significantly associated with the NSC 359239.

NSC Compound Enrichment Correlation
NSC 734406 Null 0.00163653239752573 0.0024275792
NSC 727219 2,3,4-tri-O-acetyl-1-S-dimethylarsino-1-thio- a -D-xylose 0.00172065213317242 -0.068303183
NSC 357288 LIATRIS LAEVIGATA LACTONE #2 0.00172065213317245 0.020282184
NSC 661428 Null 0.00211131723826695 0.077752781
NSC 677066 Null 0.00211131723826695 0.06965586
NSC 693983 2-Butenedioic acid, (Z)-, 2-(1,2,3,4-tetrahydro-2,4-dioxo-3-propynyl-1-pyrimidinyl)-, diethyl ester 0.00211131723826695 -0.16612942
NSC 295499 Camptothecin Derivative 0.00211131723826697 0.2694148
NSC 639512 Cyclopentanone, 2-[(4-methoxyphenyl)methylene]-5-[(4- morpholinyl)methyl]-, hydrochloride 0.00216534295403404 -0.035663629
NSC 657829 (1R)-(-)-3-Nitromethine-6-endo-acetoxycamphor 0.00216534295403404 0.027245925
NSC 671167 Null 0.00216534295403404 0.26056189
Total:74  Current:5    [First] [Prev] [Next] [Last]